Table 2.
Lineblot band intensity in Cohort A.
| Lineblot band intensity | Weak/borderline N (%) | Positive (+ / + +) N (%) | Strongly positive (+ + +) N (%) |
|---|---|---|---|
| N1 Anti-Hu | 1 (100) | – | – |
| N0 Anti-Ri | – | – | – |
| N1 Anti-Ma1/2 | 1 (100) | – | – |
| N7 Anti-amphiphysin | 6 (85.7) | 1 (14.2) | – |
| N1 Anti-CV2/CRMP5 | 1 (100) | – | – |
| N8 Anti-Yo (PCA-1) | 8 100) | – | – |
| Anti-Tr (DNER) | – | – | – |
| N10 Anti-titin | 8 (80) | 1 (10) | 1 (10) |
| N11 Anti-recoverin | 8 (72.7) | 3 (26.2) | – |
| N7 Anti-SOX-1 | 4 (57.2) | 3 (42.7) | – |
CRMP5 collapsin response-mediator protein-5, DNER Delta/Notch-like epidermal growth factor-related receptor, PCA-1 Purkinje cell cytoplasmic antibody-1.